Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01806571
Title Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin

Nilotinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.